Compugen Ltd. (CGEN) vs Anbio Biotechnology Class A Ordinary Shares (NNNN)

A side-by-side comparison of Compugen Ltd. and Anbio Biotechnology Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Compugen Ltd. logo
CGEN
Compugen Ltd.
$210M
$2.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Anbio Biotechnology Class A Ordinary Shares logo
NNNN
Anbio Biotechnology Class A Ordinary Shares
$215M
$4.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CGEN vs NNNN

growth of $100 · dividends reinvested · last 2y
CGEN -4.5% (-2.3%/yr)NNNN -16.3% (-8.5%/yr)CGEN compounded faster over this window
0200400600800Start $1002026$95$84
CGEN NNNN

CGEN vs NNNN: by the numbers

  • •NNNN is the larger company ($215M vs $210M market cap).
  • •NNNN converts more revenue to profit (74.06% vs 47.55% net margin).

Metrics side by side

Valuation

MetricCGENNNNN
P/E ratio5.91N/A
P/S ratio2.84N/A
P/B ratio2.377.13

Profitability

MetricCGENNNNN
Gross margin86.89%87.24%
Operating margin40.94%66.70%
Net margin47.55%74.06%
ROE39.66%21.24%
ROIC26.14%19.13%

Growth (annualized)

MetricCGENNNNN
Revenue CAGR (5Y)105.91%N/A
Total return CAGR (5Y)-18.39%N/A

Frequently asked

Is CGEN or NNNN more profitable?
NNNN runs the higher net margin — CGEN at 47.55% versus NNNN at 74.06%.

Go deeper

Full CGEN analysisFull NNNN analysisInteractive comparison tool

Dig into the metrics

Compugen P/E ratioCompugen ROEAnbio Biotechnology Class A Ordinary Shares ROECompugen operating marginAnbio Biotechnology Class A Ordinary Shares operating marginCompugen revenue growthAnbio Biotechnology Class A Ordinary Shares revenue growthCompugen free cash flowAnbio Biotechnology Class A Ordinary Shares free cash flow

Compugen & Anbio Biotechnology Class A Ordinary Shares appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.